GLP-1 receptor agonists are prescription medicines that help with weight loss by reducing appetite, increasing fullness after meals, slowing digestion, and supporting healthy blood sugar levels
In silico study Comparative in-silico pharmacokinetic (ADMET/PK) and safety profiles This analysis contextualizes the physicochemical differences between -carotene (BC) and doxorubicin (DOX) within the formulation lipid phosphatidylcholine (PC) using computational ADMET predictions
Why Patients Stop and What They Do Next Previous research by the same team identified two main reasons patients stop taking these medications: cost or lack of insurance coverage, and side effects
If you cannot name it in five seconds, start there
The Precision Peptide Genetic Test ($298) maps 49 genes and 58 variants across 14 health pathways including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response so the prescribing clinician knows whether a faster titration, a slower one, or a tirzepatide-first approach better fits your biology
DISCLAIMER FOR USE: All products available for purchase on the Website are intended for laboratory research purposes only and are not intended for human or animal consumption